Rydapt
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Rydapt, covering 2013-03-26 to 2026-01-14. Get the full timeline:
Most recent: EMA Authorised: Rydapt (Midostaurin) — Novartis Europharm Ltd
11 regulatory and trial events tracked for Rydapt, covering 2013-03-26 to 2026-01-14. Get the full timeline:
Most recent: EMA Authorised: Rydapt (Midostaurin) — Novartis Europharm Ltd